Key Takeaways:

  • The increasing demand for biopharmaceuticals, the growing popularity of single-use technologies, and advancements in bioprocessing and chromatography technologies are driving the growth of the downstream processing market.
  • BThe biopharmaceutical segment dominated the downstream processing market in 2020 and is expected to continue to lead the market during the forecast period due to the high demand for biopharmaceutical products.
  • The chromatography segment is expected to grow at the highest CAGR during the forecast period due to the increasing adoption of chromatography techniques for the separation and purification of biomolecules.
  • North America dominated the downstream processing market in 2020 due to the presence of major biopharmaceutical companies and a well-established healthcare infrastructure. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the increasing adoption of biopharmaceutical products in the region.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/2862

The global Downstream Processing Market was estimated at $21.8 billion in 2020 and is expected to hit $92.0 billion by 2030, registering a CAGR of 13.5% from 2021 to 2030.

Market Drivers

  • Increasing demand for biopharmaceuticals: The demand for biopharmaceuticals has been increasing rapidly due to their high effectiveness and specificity in treating diseases. Downstream processing plays a crucial role in the production of biopharmaceuticals, which is driving the growth of the market.
  • Growing popularity of single-use technologies: Single-use technologies have gained popularity in recent years due to their cost-effectiveness, flexibility, and reduced risk of contamination. Downstream processing is increasingly adopting single-use technologies, which is driving the growth of the market.

Market Segmentation

  • Product: The downstream processing market can be segmented by product into chromatography columns and resins, filters, membrane adsorbers, single-use products, evaporators, centrifuges, dryers, and others.
  • Technique: The downstream processing market can be segmented by technique into chromatography, filtration, centrifugation, membrane separation, and other techniques.
  • Application: The downstream processing market can be segmented by application into monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, enzyme production, and others.
  • End-user: The downstream processing market can be segmented by end-user into biopharmaceutical manufacturers, contract research and manufacturing organizations (CROs/CMOs), and academic and research institutes.

Request for Customization

https://www.alliedmarketresearch.com/request-for-customization/2862

Competitive Landscape

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • GE Healthcare
  • Danaher Corporation
  • Sartorius Stedim Biotech S.A.
  • 3M Company
  • Repligen Corporation
  • Lonza Group AG
  • Eppendorf AG
  • Corning Incorporated

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/2862

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives

Browse more latest healthcare reports:

Skin Biopsy Market by Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy), by Indication (Skin cancer, Actinic keratosis, Dermatitis, Others), by End User (Hospital and Clinics, Diagnostic Laboratories, Other): Global Opportunity Analysis and Industry Forecast, 2021-2031

Dystonia Drugs Market by Drug Type (Dopaminergic agents, GABAergic agents, Anticonvulsants drugs, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us:

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. 

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. 

Contact: 

David Correa 

5933 NE Win Sivers Drive 

#205, Portland, OR 97220 

United States 

USA/Canada (Toll Free): 

+1-800-792-5285, +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1(855)550-5975 

help@alliedmarketresearch.com 

Web: www.alliedmarketresearch.com 

Allied Market Research Blog: https://blog.alliedmarketresearch.com  

Follow Us on | Facebook | LinkedIn | YouTube | 

Leave a comment

Your email address will not be published. Required fields are marked *